What Is Microcystin-LR? Definition and What Research Reports

Microcystin-LR (MC-LR) is a small cyclic peptide toxin produced by several genera of freshwater cyanobacteria, most commonly Microcystis, and released into water during cyanobacterial blooms. It is a heptapeptide — seven amino acid residues arranged in a ring — assembled by non-ribosomal peptide synthetase enzymes rather than by ordinary ribosomal translation. The suffix “LR” identifies the two variable amino acids in the ring, leucine (L) and arginine (R); other congeners in the same family carry different pairs and are named accordingly (for example MC-RR or MC-YR). Unlike the research peptides usually discussed in a peptide glossary, Microcystin-LR is not a candidate therapeutic: it is studied as an environmental contaminant and as a laboratory tool compound in toxicology, water-quality science and cell biology.

This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question. Nothing here describes or endorses any use of this compound.

What class of molecule is it, and where does it come from?

Microcystin-LR belongs to the microcystin family of cyclic non-ribosomal peptides. Its defining structural feature is a rare beta-amino acid residue abbreviated Adda, which is shared across the microcystin family and is the chemical signature most analytical methods target. Because the molecule is cyclic and chemically stable, it persists in water and can move into soils and sediments after a bloom collapses; a 2022 environmental study examined the behaviour and fate of microcystin-LR in soils amended with biochar and peat and reported that the amendments changed how the toxin sorbed and dissipated in the soil matrix (PMID 35961568).

In practice the term is encountered in three distinct literatures:

• Environmental and water science — occurrence, transport, degradation and removal of the toxin in surface water, drinking-water treatment and soil.
• Analytical chemistry — detection and quantification methods, including biosensors built around antibodies or aptamers.
• Mechanistic toxicology — cell-culture and animal models used to describe how the peptide interacts with intracellular signalling.

How the term is used in peptide research

Within peptide chemistry, Microcystin-LR is frequently cited as a textbook example of a bioactive cyclic peptide made by bacteria without ribosomes — a class that also includes many antibiotics. In cell-signalling work it is used as a reference perturbation because it interferes with phosphorylation balance inside cells: a 2018 study reported that microcystin-LR disrupted insulin signalling by hyperphosphorylating insulin receptor substrate 1 and glycogen synthase (PMID 28984034). That phosphorylation-centred behaviour is why the compound recurs in papers on kinase and phosphatase pathways, cytoskeletal regulation and metabolic signalling.

It is also a recurring analyte in peptide-detection engineering. Researchers describing a SERS-FET dual-mode biosensor reported qualitative and quantitative detection of microcystin-LR using the combined optical and electrical readouts of the device (PMID 35671700). Papers of this kind treat the peptide as a detection target rather than as a biological subject.

What the Published Literature Reports

The bulk of the microcystin-LR literature is mechanistic toxicology in cells, fish and rodents. Findings are model-specific and are summarised below as the authors described them.

Kidney and cell-death pathways

A study on environmental nephrotoxicity reported that microcystin-LR triggered renal tubular ferroptosis through epigenetic repression of GPX4 (PMID 41319283). A related finding in fish: researchers reported that microcystin-LR induced ferroptosis in the intestine of common carp (Cyprinus carpio) (PMID 34365207). Ferroptosis is an iron-dependent form of regulated cell death, and GPX4 is the enzyme that normally restrains it.

Glucose handling and insulin signalling

One 2020 report described impaired glucose metabolism in pancreatic beta cells after microcystin-LR exposure, in vivo and in vitro (PMID 32142839). That observation sits alongside the earlier signalling study in which the authors reported hyperphosphorylation of insulin receptor substrate 1 and glycogen synthase (PMID 28984034).

Immune and inflammatory responses

Researchers reported that microcystin-LR triggered inflammatory responses in macrophages in a 2021 cell-based investigation (PMID 34576099).

Cytoskeleton, cell phenotype and invasion

In DU145 prostate cancer cells, the study reported that microcystin-LR induced microfilament rearrangement and cell invasion by activating the ERK/VASP/ezrin pathway (PMID 35248587). A separate 2024 paper reported that microcystin-LR-induced epithelial–mesenchymal transition-like cells acquired resistance to multiple toxins (PMID 38163460).

Mitochondria and respiratory tissue

An environmental toxicology study reported that subacute and sublethal ingestion of microcystin-LR impaired lung mitochondrial function through what the authors characterised as an oligomycin-like effect on ATP synthase (PMID 35598755). Not every respiratory model produced a signal: a 2020 report in human bronchial epithelial cells found that microcystin-LR did not alter cell survival or intracellular signalling in that system (PMID 32156079). The contrast is a reminder that cell type, route and exposure design shape the outcome.

Developmental models and modifiers

Work in zebrafish larvae examined whether co-exposure could modify toxicity; researchers reported that probiotics alleviated microcystin-LR-induced developmental toxicity in that larval model (PMID 39058179).

Toxicity Findings in Research Models: What Studies Report

Because microcystin-LR is studied as a toxin rather than as a candidate drug, the “effects” literature is an adverse-effects literature by definition. Across the verified studies, the reported endpoints clustered around cell death pathways, metabolic signalling, inflammation and mitochondrial function.

Limits of the current evidence

Three limitations recur across this body of work. First, nearly all of the mechanistic findings above came from cultured cells, fish or rodents, not from controlled human studies. Second, results were not uniform between tissues — ferroptosis in renal tubules (PMID 41319283) contrasted with the absence of survival or signalling changes reported in human bronchial epithelial cells (PMID 32156079). Third, environmental exposure is rarely to a single congener, whereas laboratory studies generally isolate MC-LR alone; work on soil amendments illustrated how much the surrounding matrix can change the toxin's behaviour (PMID 35961568).

Related terminology

• Microcystins — the family of cyclic heptapeptide cyanotoxins to which MC-LR belongs.
• Adda residue — the unusual beta-amino acid common to the microcystin family and a frequent analytical target.
• Cyanobacterial harmful algal bloom (cyanoHAB) — the bloom event during which these peptides accumulate in surface water.
• Ferroptosis — the iron-dependent cell-death pathway reported in several of the studies above.

In short, Microcystin-LR is best understood as a naturally occurring cyclic peptide toxin and a research analyte — a term that appears in peptide science through environmental monitoring, analytical method development and mechanistic toxicology, rather than through any therapeutic literature. Again, this entry is educational only and is not medical advice.

References

• Probiotics Alleviate Microcystin-LR-Induced Developmental Toxicity in Zebrafish Larvae (Toxics, 2024)
• Behavior and fate of microcystin-LR in soils amended with biochar and peat (Environmental Pollution, 2022)
• Microcystin-LR Triggers Renal Tubular Ferroptosis Through Epigenetic Repression of GPX4: Implications for Environmental Nephrotoxicity (Advanced Science, 2026)
• Microcystin-LR-induced epithelial-mesenchymal transition-like cells acquire resistance to multi-toxins (Toxicon, 2024)
• Microcystin-LR impairs glucose metabolism in pancreatic β cells in vivo and in vitro (Toxicology Letters, 2020)
• Microcystin-LR (MC-LR) Triggers Inflammatory Responses in Macrophages (International Journal of Molecular Sciences, 2021)
• Microcystin-LR disrupts insulin signaling by hyperphosphorylating insulin receptor substrate 1 and glycogen synthase (Environmental Toxicology, 2018)
• Subacute and sublethal ingestion of microcystin-LR impairs lung mitochondrial function by an oligomycin-like effect (Environmental Toxicology and Pharmacology, 2022)
• Microcystin-LR induced microfilament rearrangement and cell invasion by activating ERK/VASP/ezrin pathway in DU145 cells (Toxicon, 2022)
• Qualitative and quantitative detection of microcystin-LR based on SERS-FET dual-mode biosensor (Biosensors & Bioelectronics, 2022)
• Microcystin-LR Does Not Alter Cell Survival and Intracellular Signaling in Human Bronchial Epithelial Cells (Toxins, 2020)
• Microcystin-LR induces ferroptosis in intestine of common carp (Cyprinus carpio) (Ecotoxicology and Environmental Safety, 2021)